Home Tags GSK
GlaxoSmithKline will be broken up in a megadeal with Pfizer that could change the face of global healthcare
The joint venture could have combined sales of nearly $10 billion.
The pharma giant GlaxoSmithKline just acquired the cancer-drug maker Tesaro for $5.1 billion in a bid to bulk up its cancer pipeline.
Shingrix, a new shingles vaccine by drugmaker GlaxoSmithKline, was approved for use by the FDA in 2017. It is currently experiencing shortages due to high demands. Shingrix is significantly more effective than Zostavax, which was the shingles vaccine that has been used since 2006.
"23andMe has created a research platform to enable interested customers to participate in research - to not wait for solutions to appear, but for people to come together and make discoveries happen," 23andMe's CEO wrote. "By working with GSK, we believe we will accelerate the development of breakthroughs."
DNA-testing company 23andMe has signed a $300 million deal with a drug giant. Here’s how to delete your data if that freaks you out.
Genetics-testing companies like Ancestry and 23andMe can — and frequently do — sell your data to drugmakers. A $300 million deal between 23andMe and the pharmaceutical giant GlaxoSmithKline is the latest example. If that has you thinking about how these companies use your data, here's how to delete it.
The consumer genetics company 23andMe is teaming up with the UK drug giant GlaxoSmithKline to develop new drugs. As part of the four-year collaboration, GSK is committing $300 million to 23andMe and is working on an experimental drug to treat Parkinson's disease.
The Food and Drug Administration, oversees among other things drug approvals. On Thursday, the agency published a list of 52 drugs it deemed are facing delays to getting generic versions because of "gaming" happening on the part of brand drugmakers.
The treatment made by Gilead combines three drugs into one daily pill: bictegravir, emtricitabine and tenofovir alafenamide.
GlaxoSmithKline CEO Emma Walmsley made history in 2017, when she became the first woman to head up a major pharmaceutical company.
DIGITAL HEALTH BRIEFING: Viant, GSK partner for blockchain in pharmaceuticals — CMS moves to increase the use of digital health solutions &...
Blockchain startup Viant announced a new collaboration with pharmaceutical giant GlaxoSmithKline (GSK), Microsoft, and others to develop supply chain solutions.